P2613
ProteoMass™ P14R MALDI-MS Standard
vial of 10 nmol
Synonyme(s) :
P14R
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderform
solid
Quality Level
mol wt
monoisotopic mol wt 1,532.8582 Da
packaging
vial of 10 nmol
storage temp.
−20°C
Application
Peptide calibration standard for MALDI-MS instruments.
Legal Information
ProteoMass is a trademark of Sigma-Aldrich Co. LLC
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Articles
One of the most important aspects of our ultra-pure MALDI matrix substances is their ability to dissolve rapidly and completely; a brief vortex mixing is typically sufficient.
Contenu apparenté
Peiyuan Tong et al.
Clinica chimica acta; international journal of clinical chemistry, 489, 154-161 (2018-12-12)
Chronic kidney disease (CKD) is a worldwide public health problem. To detect discriminating salivary peptide profiles between CKD patients undergoing haemodialysis (HD) and healthy controls (HCs) and to screen candidate biomarkers for CKD, we preliminarily explored the diagnostic potentiality of
Shuang Ao et al.
Journal of dentistry, 61, 21-27 (2017-04-26)
To investigate differentially expressed salivary peptides in the development of early childhood caries (ECC) in 3-4 year-old children. Eighty-two caries-free children at baseline were followed-up for 1year, during which period 15 of them had developed ECC (Group C), whilst another
Chang Tian et al.
PloS one, 12(8), e0182712-e0182712 (2017-08-16)
This study aimed to identify differences of peptide profiles in stimulated whole saliva among children with and without occurrence of new carious lesions, and to provide a simple way for early diagnosis and prevention of the relapse of severe early
Numéro d'article de commerce international
| Référence | GTIN |
|---|---|
| P2613-1VL | 04061838243294 |
| P2613-5X1VL | 04061833296639 |